Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis

被引:381
作者
Altamura, Sandro [1 ]
Muckenthaler, Martina U. [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Pediat Oncol Haematol & Immunol, Mol Med Partnership Unit, D-69120 Heidelberg, Germany
关键词
Alzheimer's disease; atherosclerosis; diseases of aging; iron; iron homeostasis; mouse model; Parkinson's disease; reactive oxygen species; CORONARY-ARTERY-DISEASE; EASTERN FINNISH MEN; RECESSIVE JUVENILE PARKINSONISM; HEMOCHROMATOSIS GENE-MUTATIONS; EARLY EMBRYONIC LETHALITY; LOW-DENSITY-LIPOPROTEIN; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PEPTIDES; TRANSFERRIN C2 ALLELE; SMOOTH-MUSCLE CELLS;
D O I
10.3233/JAD-2009-1010
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Excess free iron generates oxidative stress that hallmarks diseases of aging. The observation that patients with Alzheimer's disease or Parkinson's disease show a dramatic increase in their brain iron content has opened the possibility that disturbances in brain iron homeostasis may contribute to the pathogenesis of these disorders. While the reason for iron accumulation is unknown, iron localization correlates with the production of reactive oxygen species in those areas of the brain that are prone to neurodegeneration. A role for iron is also proposed in atherosclerosis, a further frequent disorder of aging. We will review experimental evidences for an involvement of iron in these diseases and discuss some mouse models with impairment in iron-related genes that may be useful to study the role of iron in these disorders.
引用
收藏
页码:879 / 895
页数:17
相关论文
共 204 条
[1]
GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology [J].
Al-Mahdawi, Sahar ;
Pinto, Ricardo Mouro ;
Varshney, Dhaval ;
Lawrence, Lorraine ;
Lowrie, Margaret B. ;
Hughes, Sian ;
Webster, Zoe ;
Blake, Julian ;
Cooper, J. Mark ;
King, Rosalind ;
Pook, Mark A. .
GENOMICS, 2006, 88 (05) :580-590
[2]
Alzheimer A., 1907, Allg. Z. Psychiatr. Psych.-Gerichtl. Med., V18, P177, DOI [DOI 10.1002/CA.980080612, 10.1002/ca.980080612]
[3]
Annichino-Bizzacchi JM, 2000, J CARDIOVASC RISK, V7, P37
[4]
NORMAL DEPOSITION OF BRAIN IRON IN CHILDHOOD AND ADOLESCENCE - MR IMAGING AT 1.5 T [J].
AOKI, S ;
OKADA, Y ;
NISHIMURA, K ;
BARKOVICH, AJ ;
KJOS, BO ;
BRASCH, RC ;
NORMAN, D .
RADIOLOGY, 1989, 172 (02) :381-385
[5]
IRON OVERLOAD AUGMENTS THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN RABBITS [J].
ARAUJO, JA ;
ROMANO, EL ;
BRITO, BE ;
PARTHE, V ;
ROMANO, M ;
BRACHO, M ;
MONTANO, RF ;
CARDIER, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1172-1180
[6]
Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein [J].
Arawaka, S ;
Saito, Y ;
Murayama, S ;
Mori, H .
NEUROLOGY, 1998, 51 (03) :887-889
[7]
SERUM FERRITIN IS NOT A RISK FACTOR FOR CORONARY-ARTERY DISEASE IN MEN AND WOMEN AGED GREATER-THAN-OR-EQUAL-TO-62 YEARS [J].
ARONOW, WS .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (03) :347-348
[8]
Characterization of copper interactions with Alzheimer amyloid β peptides:: Identification of an attomolar-affinity copper binding site on amyloid β1-42 [J].
Atwood, CS ;
Scarpa, RC ;
Huang, XD ;
Moir, RD ;
Jones, WD ;
Fairlie, DP ;
Tanzi, RE ;
Bush, AI .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :1219-1233
[9]
Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin [J].
Babcock, M ;
deSilva, D ;
Oaks, R ;
DavisKaplan, S ;
Jiralerspong, S ;
Montermini, L ;
Pandolfo, M ;
Kaplan, J .
SCIENCE, 1997, 276 (5319) :1709-1712
[10]
SOLUTION CONFORMATIONS AND AGGREGATIONAL PROPERTIES OF SYNTHETIC AMYLOID BETA-PEPTIDES OF ALZHEIMERS-DISEASE - ANALYSIS OF CIRCULAR-DICHROISM SPECTRA [J].
BARROW, CJ ;
YASUDA, A ;
KENNY, PTM ;
ZAGORSKI, MG .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) :1075-1093